Insys Therapeutics, Inc. 4
4 · Insys Therapeutics, Inc. · Filed May 18, 2015
Insider Transaction Report
Form 4
BAKER DARRYL S
Chief Financial Officer
Transactions
- Sale
Common Stock
2015-05-18$58.83/sh−4,000$235,320→ 9,377 total - Sale
Common Stock
2015-05-18$59.40/sh−6,000$356,400→ 13,377 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.21 to $59.62 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.25 to $59.17 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.